Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
Bridging the Gap

  From Medical Biochemistry to Clinical Trials

  Steve Coney – Manufacturing Scientist
  Pharmaceutical Profiles Ltd
  12 March 2009




03/12/09                       Pharmaceutical Profiles
                                                         1
Who are Pharmaceutical Profiles?


• Nottingham University spin out
     – 1990, School of Pharmaceutical Sciences

• Unique and differentiated technology

• Approximately 100 people
     – 20,000 ft2 Ruddington, Nottingham

• >30 clinical studies per year
     – Global customer base
     – 65% USA, 25% Europe, 10% Japan


 03/12/09                       Pharmaceutical Profiles
How do we make our money?

       Clinical investigation of bioavailability issues
       • Application of novel technologies and
          methodologies to understand how to build an
          optimal drug formulation for man
           – EnterionTM, iv MicroTracer PK, pharmacoscintigraphy

       Rapid evaluation of new formulations in man
       • Integrated manufacturing and clinical evaluation to
         enable rapid evaluation and validation of test
         formulations
           – Oral, inhaled, intravenous, and intranasal routes of delivery



03/12/09                          Pharmaceutical Profiles
The Enterion Capsule




03/12/09             Pharmaceutical Profiles
What do we do?

                           Manufacturing               Clinical
                                                                    GCP Facility, 30 beds
    GMP Facility
                                                                   Phase 0 microdosing
    Formulation R&D
                                                                   IV PK & Metabolism
    Analytical R&D
                                                                   Phase I
    Radiolabelling
                                                                   Phase IIa POC
    CT manufacture




                                                                  Pharmacoscintigraphy
   Remote controlled
                                                                  Formulation validation
   Targeted within GI
                                                                  Gastric emptying/motility
   Multiple dosage forms
                                                                  Lung / nasal deposition

                                                        Imaging
                             Enterion TM
                             Enterion                   Imaging



03/12/09                             Pharmaceutical Profiles
Who do we work for?


• Worked with the majority of top 30
  pharma companies
• Over 250 biotechnology companies
   • Greater than 30 marketed oral drugs
     • >50 oral drugs currently in development
     • 16 of the top 100 selling drugs




03/12/09                           Pharmaceutical Profiles
What can we do?

                                   •Radiolabelled egg
           Enterion capsules
       •
                                                             Routes of
                                                             administration
                                   •Radiolabelled drink
           Tablets
       •
                                                             •   Oral
                                   •Nasal sprays
           Capsules                                          •   Intravenous
       •
                                                             •   Inhaled
                                   •pMDIs
                                                             •   Intranasal
           Solutions
       •
                                                             •   Rectal
                                   •Powder inhalers
                                                             •   Intravaginal
           Aseptic manipulations
       •
                                                             •   Dermal
                                   •Nebulised doses
           Ointments & creams
       •
                                   •14C-microdoses
           Neutron Activation
       •
                                   •Encapsulation

03/12/09                           Pharmaceutical Profiles
Clinical Trials – an Overview

       • Four main stages:
           –   Phase I     Initial human testing - safety
           –   Phase II    Dose finalisation
           –   Phase III   Therapeutic trials
           –   Phase IV    Post-marketing safety monitoring
       • Also one further stage:
           – Phase 0       “microdosing”




03/12/09                     Pharmaceutical Profiles
Where does PP fit in?

       • Mainly Phases 0, I and II (although some III)

       • Market leader in Phase 0 IV 14C-microdosing




03/12/09                     Pharmaceutical Profiles
About Me

       • Graduated 2006 BSc(hons) Medical Biochemistry

       • June 2006-April 2007 UHL Nursing Auxilliary

       • Joined PP April 2007

       • Married June 2007




03/12/09                     Pharmaceutical Profiles
What do I do?

       • Manufacturing Scientist

       • Prepare Investigational Medicinal Products (IMPs)

       • Manage supplies

       • Perform in vitro experiments

       • Trained to handle radioactive materials


03/12/09                    Pharmaceutical Profiles
How do you get into Clinical Trials?


       • Apply for jobs

       • Gain experience in the Pharmaceutical/Food
         Industry

       • Many roles requiring Bioscience graduates

       • Volunteer!!




03/12/09                    Pharmaceutical Profiles
Any Questions?




03/12/09          Pharmaceutical Profiles
                                            13

More Related Content

Manufacturing Scientist

  • 1. Bridging the Gap From Medical Biochemistry to Clinical Trials Steve Coney – Manufacturing Scientist Pharmaceutical Profiles Ltd 12 March 2009 03/12/09 Pharmaceutical Profiles 1
  • 2. Who are Pharmaceutical Profiles? • Nottingham University spin out – 1990, School of Pharmaceutical Sciences • Unique and differentiated technology • Approximately 100 people – 20,000 ft2 Ruddington, Nottingham • >30 clinical studies per year – Global customer base – 65% USA, 25% Europe, 10% Japan 03/12/09 Pharmaceutical Profiles
  • 3. How do we make our money? Clinical investigation of bioavailability issues • Application of novel technologies and methodologies to understand how to build an optimal drug formulation for man – EnterionTM, iv MicroTracer PK, pharmacoscintigraphy Rapid evaluation of new formulations in man • Integrated manufacturing and clinical evaluation to enable rapid evaluation and validation of test formulations – Oral, inhaled, intravenous, and intranasal routes of delivery 03/12/09 Pharmaceutical Profiles
  • 4. The Enterion Capsule 03/12/09 Pharmaceutical Profiles
  • 5. What do we do? Manufacturing Clinical GCP Facility, 30 beds GMP Facility Phase 0 microdosing Formulation R&D IV PK & Metabolism Analytical R&D Phase I Radiolabelling Phase IIa POC CT manufacture Pharmacoscintigraphy Remote controlled Formulation validation Targeted within GI Gastric emptying/motility Multiple dosage forms Lung / nasal deposition Imaging Enterion TM Enterion Imaging 03/12/09 Pharmaceutical Profiles
  • 6. Who do we work for? • Worked with the majority of top 30 pharma companies • Over 250 biotechnology companies • Greater than 30 marketed oral drugs • >50 oral drugs currently in development • 16 of the top 100 selling drugs 03/12/09 Pharmaceutical Profiles
  • 7. What can we do? •Radiolabelled egg Enterion capsules • Routes of administration •Radiolabelled drink Tablets • • Oral •Nasal sprays Capsules • Intravenous • • Inhaled •pMDIs • Intranasal Solutions • • Rectal •Powder inhalers • Intravaginal Aseptic manipulations • • Dermal •Nebulised doses Ointments & creams • •14C-microdoses Neutron Activation • •Encapsulation 03/12/09 Pharmaceutical Profiles
  • 8. Clinical Trials – an Overview • Four main stages: – Phase I Initial human testing - safety – Phase II Dose finalisation – Phase III Therapeutic trials – Phase IV Post-marketing safety monitoring • Also one further stage: – Phase 0 “microdosing” 03/12/09 Pharmaceutical Profiles
  • 9. Where does PP fit in? • Mainly Phases 0, I and II (although some III) • Market leader in Phase 0 IV 14C-microdosing 03/12/09 Pharmaceutical Profiles
  • 10. About Me • Graduated 2006 BSc(hons) Medical Biochemistry • June 2006-April 2007 UHL Nursing Auxilliary • Joined PP April 2007 • Married June 2007 03/12/09 Pharmaceutical Profiles
  • 11. What do I do? • Manufacturing Scientist • Prepare Investigational Medicinal Products (IMPs) • Manage supplies • Perform in vitro experiments • Trained to handle radioactive materials 03/12/09 Pharmaceutical Profiles
  • 12. How do you get into Clinical Trials? • Apply for jobs • Gain experience in the Pharmaceutical/Food Industry • Many roles requiring Bioscience graduates • Volunteer!! 03/12/09 Pharmaceutical Profiles
  • 13. Any Questions? 03/12/09 Pharmaceutical Profiles 13